Condition: Scapular Dyskinesis · Sponsor: Riphah International University
Scapular dyskinesia is defined by abnormal movement or placement of the scapula, the shoulder blade, during arm movements. Physical treatment aimed at regaining appropriate scapular mechanics through strengthening exercises, postural correction, and functional movement training is typically part of management. A randomized clinical trial will be conducted. The study will be conducted at Unique school and on school going children in a total duration of 10 months. Sample size will be 22.There will be two study groups. A convenient sampling technique will be used. The sample which will have following characteristics will be included children with age group 9 to 12 years, positive scapular test, positive scapular assistance test, athletes who practice one hour three days a week. The sample with the following characteristics will be excluded. Any muscular or joint deformity, scoliosis, shoulder dislocation. The tools that will be included in the study are modified lateral scapular test, shoulder flexion test, shoulder and pain disability index, upper extremity functional use scale, posture and posture assessment scale, shoulder and scapular ranges.
This description comes directly from the study's public registry record.
Imran Amjad, PHD · 9233224390125 · imran.amjad@riphah.edu.pk
Muhammad Asif Javed, MS-PT · 923224209422 · a.javed@riphah.edu.pk
Always discuss trial participation with your own doctor first.
| Mishal Farwa | Lahore, Punjab Province, Pakistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06943131